source
- Endpoints 11 reveals 2026’s most promising biotech startups at Boston galaThe Endpoints editorial team announced the Endpoints 11 list, highlighting the most exciting biotech startups of 2026. The selection process involved months of research, interviews with executives,…
- Startup launches trial of psychedelic-style drug for Parkinson’s symptomA new biotech startup announced it will begin preclinical testing of a psychedelic-like compound aimed at alleviating a specific symptom of Parkinson’s disease. The company plans to evaluate the d…